A number of research firms have changed their ratings and price targets for General Motors (NYSE: GM): 10/30/2026 – General Motors was upgraded by Weiss Ratings from “hold (c)” to “buy (b-)”. 10/28/2026 – General Motors had its price target raised by Tigress Financial from $130.00 to $132.00. They now have a “strong-buy” rating on […]

Enerflex (TSE: EFX) recently received a number of ratings updates from brokerages and research firms: 10/30/2026 – Enerflex had its price target lowered by Royal Bank Of Canada from C$35.00 to C$33.00. They now have an “outperform” rating on the stock. 10/26/2026 – Enerflex had its price target raised by National Bank Financial from C$42.50 […]

A number of research firms have changed their ratings and price targets for LPL Financial (NASDAQ: LPLA): 10/29/2026 – LPL Financial had its price target lowered by UBS Group from $390.00 to $369.00. They now have a “buy” rating on the stock. 10/28/2026 – LPL Financial had its “buy” rating reaffirmed by The Goldman Sachs […]

NXP Semiconductors (NASDAQ: NXPI) has recently received a number of price target changes and ratings updates: 10/29/2026 – NXP Semiconductors had its “hold (c+)” rating reaffirmed by Weiss Ratings. 10/28/2026 – NXP Semiconductors had its price target raised by TD Cowen from $275.00 to $280.00. They now have a “buy” rating on the stock. 10/28/2026 […]

Eldorado Gold (TSE: ELD) has recently received a number of price target changes and ratings updates: 11/2/2026 – Eldorado Gold had its price target lowered by National Bank Financial from C$74.00 to C$68.00. They now have an “outperform” rating on the stock. 10/30/2026 – Eldorado Gold had its price target lowered by ATB Cormark Capital […]

A number of research firms have changed their ratings and price targets for Caris Life Sciences (NASDAQ: CAI): 10/27/2026 – Caris Life Sciences had its price target raised by BTIG Research from $33.00 to $38.00. They now have a “buy” rating on the stock. 10/19/2026 – Caris Life Sciences had its price target raised by […]

A number of research firms have changed their ratings and price targets for Arrowhead Pharmaceuticals (NASDAQ: ARWR): 10/15/2026 – Arrowhead Pharmaceuticals is now covered by UBS Group. They set a “buy” rating and a $109.00 price target on the stock. 10/15/2026 – Arrowhead Pharmaceuticals had its “buy” rating reaffirmed by Chardan Capital. They now have […]

A number of firms have modified their ratings and price targets on shares of Chefs’ Warehouse (NASDAQ: CHEF) recently: 10/29/2026 – Chefs’ Warehouse had its price target raised by UBS Group from $125.00 to $135.00. They now have a “buy” rating on the stock. 10/29/2026 – Chefs’ Warehouse had its price target raised by Morgan […]

Several analysts have recently updated their ratings and price targets for EPAM Systems (NYSE: EPAM): 11/2/2026 – EPAM Systems had its price target raised by Guggenheim from $140.00 to $160.00. They now have a “buy” rating on the stock. 10/26/2026 – EPAM Systems had its price target raised by Citigroup from $100.00 to $140.00. They […]

Several analysts have recently updated their ratings and price targets for Veradermics (NYSE: MANE): 10/22/2026 – Veradermics was given a new $204.00 price target by UBS Group. 10/22/2026 – Veradermics had its price target raised by B. Riley Financial from $170.00 to $204.00. They now have a “buy” rating on the stock. 10/19/2026 – Veradermics […]